CVS Health released better-than-expected first-quarter financial results before the markets opened on Wednesday.
24/7 Wall St. takes a look at what is expected from CVS Health, Hewlett Packard Enterprise, Walmart and some of the other key companies reporting earnings this coming week.
A gold miner, a health insurer and a maker of consumer staple goods will report quarterly earnings before markets open on Wednesday.
An unusually large block of put contracts in CVS Health has been sold.
CVS Health has faced strong headwinds since last year’s acquisition of health insurer Aetna, but its upcoming earnings report could prove to be a turning point.
One thing retailers have -- or should have learned -- is not to underestimate the power of Apple in the consumer world.
Rite Aid Corp. (NYSE: RAD) is indicated to open lower after the company posted another net loss for the quarter.  It also lowered guidance for a second time.  We just noted this one as a...
November 8, 2016: Here are four stocks trading with relatively heavy volume among 128 equities making new 52-week lows in Tuesday’s session. On the NYSE, advancers led decliners by nearly 3 to...
24/7 Wall St. has put together a preview of Disney, Sprint, Uber and a few of the other most anticipated earnings reports due this week.
An unusually large block of put contracts in CVS Health has been sold.
CVS Health shares retreated after it reported mixed fourth-quarter financial results and lower guidance early Wednesday.
Tonight’s MAD MONEY on CNBC was a different section than the normal stock picking.  Jim Cramer wanted to cover execution of a business model (or business plan): Cramer’s first...
Rite Aid Corp. (NYSE: RAD) just can’t seem to get it right.  Whatever the strategy is intended to be doing, it needs a real change in the world of a CVS, Walgreen, and Wal-Mart dominance.  The...
Pharmacy and health insurer CVS handily beat expected earnings and revenue estimates for the second quarter.
The retailer people most regret buying gifts from is CVS, according to a 24/7 Wall St. analysis.